July Some of the microbiome-related papers published this month prompted active discussions on social media—highlighting just how much we’re learning, but also how hard it is to interpret the data at times. Listed here are […]
uBiome, Inc., announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in Delaware to facilitate an orderly and efficient sale of its ongoing business, products in development, technology, and […]
This Probiota edition finally set foot in the country with the most effective regulation around probiotics, Canada, on 24-26 June 2019 in Vancouver! NutraIngredients USA introduced the Wellness Program, proposing attendees to walk, run, practice […]
Studies presented at leading microbiome conferences have grown in sophistication over the past several years and have uncovered important mechanistic links between the microbiome and aspects of host health. In fact, certain microorganisms (Akkermansia, Faecalibacterium […]
Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint […]
The pathogen Clostridium difficile, which causes one of the most common hospital-acquired infections in the United States, may have accomplices that until now have gone largely unnoticed. This week in mSphere, researchers report finding fungi […]
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, announced completion of construction of a new state-of-the-art manufacturing facility. The new facility is located at the company’s headquarters in Ness Ziona and […]
How many stars are there in the observable universe? It was once deemed an impossible question, but astronomers have gleaned an answer–about one billion trillion of them. Now, scientists at Harvard Medical School and Joslin […]
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna International Group (SIG), Symbiosis LLC and […]
The National Microbiome Data Collaborative (NMDC), a new initiative aimed at empowering microbiome research, is gearing up its pilot phase after receiving $10 million from the U.S. Department of Energy (DOE) Office of Science. Spearheaded […]
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response, a […]